Skip to content
MS
Sign in
Junction / hub Pathway metabolite unreviewed

IMP

0
Pathways
0
Categories
0
As substrate
0
As product
What can this become? Show on map

Reactions involving IMP

Every recorded step where this molecule takes part

All 6 Consumed 3 Produced 3

Showing all 6 reactions.

Pathway junctions through this molecule

Produced in one pathway, consumed in another

4 links
Produced in Consumed in Link
Purine De Novo Synthesis (IMP synthesis thr… → Purine Degradation (to Uric Acid) within category
Purine Degradation (to Uric Acid) → Purine De Novo Synthesis (IMP synthesis thr… within category
Purine Salvage Pathway → Purine De Novo Synthesis (IMP synthesis thr… within category
Purine Salvage Pathway → Purine Degradation (to Uric Acid) within category

Recent literature

Refresh

Europe PMC · from cache · sorted by publication date

  1. 1
    Enhanced lactose utilization from milk enriched in Uridine-5'-monophosphate drives hepatic energy storage in young mammals.

    Gao LM, Liu L, Yang XD, Long CM, Wu X. · 2026-06-01

    open access unreviewed
  2. 2
    Cardiovascular-kidney-metabolic syndrome through the lens of gut‑derived uremic toxins.

    Xu C, Snelson M, Marques FZ. · 2026-06-15

    open access unreviewed
  3. 3
    Oral self-assembly nanoemulsion drives <i>in vivo</i> hepatic stellate cell-targeting drug delivery in liver fibrosis.

    Shen X, Deng J, Jiang A, Cai Q, Tian D, Zhao L, Ye J, Zhang L, Xiang Y, Zhang Q. · 2026-06-12

    open access unreviewed
  4. 4
    The mediating role of motives in the associations between the big five personality traits and marijuana outcomes: A cross-national study across four countries.

    Mezquita L, Bravo AJ, Pilatti A, Vidal-Arenas V, Ortet G, Ibáñez MI, Cross-Cultural Addictions Study Team. · 2026-05-27

    open access unreviewed
  5. 5
    From gut microbiota metabolism to microvascular injury: Exploring the role and mechanisms of gut microbiota in obesity-induced coronary microcirculation dysfunction.

    Liu Y, Wang Y, Teng H, Nie W, Qiao X, Shen Y, Wang Z, Yao X. · 2026-06-02

    open access unreviewed
  6. 6
    Chikungunya virus nsP2: Insights into viral replication, pathogenesis, and therapeutic targeting.

    Xu S, Li K, Tan Q, Yuan L, Huang R, Feng Y, Xu K, Zhu Z, Deng L, Deng Y, Ren Y, Yang J, Yang X. · 2026-05-25

    open access unreviewed
  7. 7
    RecC<sup>935H</sup> is associated with divergent evolutions of clonal group 258 <i>Klebsiella pneumoniae</i>.

    Hu D, Ye X, Wang J, Mi S, Sun J, Dai P, Huang T, Zhang J, Luo X, Ma Q, Jiang X, Wu S, Zhang H. · 2026-05-19

    open access unreviewed
  8. 8
    Gut microbiota and immunometabolism in obesity.

    Torres-Mayo A, Liébana-García R, Olivares M, Pellón A, Anguita J, Sanz Y. · 2026-05-05

    cited 1× open access unreviewed
  9. 9
    <i>Acinetobacter baumannii</i>: Mechanisms of antibiotic resistance, quorum sensing regulation, and current therapeutic strategies.

    Fortaleza JAG, Cabuhat KSP, Ong CJN, Mortel FA, Bacalzo GD, Nuevo JJM. · 2026-05-04

    open access unreviewed
  10. 10
    An oral-gut microbial metabolite links <i>Fusobacterium nucleatum</i> to aggravated myocardial ischemia-reperfusion injury.

    Li Y, Xu Q, Zhu M, Wang W, Liu Y, Yang H, Liu Y. · 2026-04-25

    open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.